480 results on '"Liu, Zhaoyun"'
Search Results
2. Immune checkpoint inhibitors for multiple myeloma immunotherapy
3. PR status is a more decisive factor in efficacy of adding pertuzumab into neoadjuvant therapy for HER2-positive and lymph node-positive breast cancer than ER status: a real-world retrospective study in China
4. Cyperotundone combined with adriamycin induces apoptosis in MCF-7 and MCF-7/ADR cancer cells by ROS generation and NRF2/ARE signaling pathway
5. Imaging the metabolic reprograming of fatty acid synthesis pathway enables new diagnostic and therapeutic opportunity for breast cancer
6. The value of serum IL-4 to predict the survival of MDS patients
7. A self-reported symptom-based decision-making model helps to rule out outpatient cases at low risk for CRC before colonoscopy
8. Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming
9. Immunophenotypic changes of monocytes in myelodysplastic syndrome and clinical significance
10. ACT001 inhibits primary central nervous system lymphoma tumor growth by enhancing the anti-tumor effect of T cells
11. Targeting NKG2D/NKG2DL axis in multiple myeloma therapy
12. Immune profiles to predict bortezomib-based treatment response for multiple myeloma patients
13. Use of roxadustat (FG-4592) in ruxolitinib-treatment-related anemia of two myelofibrosis patients
14. Long noncoding RNA FAM157C contributes to clonal proliferation in paroxysmal nocturnal hemoglobinuria
15. Folic acid-coupled bovine serum albumin-modified magnetic nanocomposites from quantum-sized Fe3O4 and layered double hydroxide for actively targeted delivery of 5-fluorouracil
16. Challenges and strategies associated with CAR-T cell therapy in blood malignancies
17. The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy
18. Vertical evolution of the concentrations and sources of volatile organic compounds in the lower boundary layer in urban Beijing in summer
19. Selinexor synergizes with azacitidine to eliminate myelodysplastic syndrome cells through p53 nuclear accumulation
20. Construction of pH-responsive nanoplatform from stable magnetic nanoparticles for targeted drug delivery and intracellular imaging
21. The urgent need to control volatile organic compound pollution over the Qinghai-Tibet Plateau
22. A recyclable photocatalyst Cu2O/Fe3O4@C/Cu nanocomposite for efficient photocatalytic reduction of 4-nitrophenol
23. PIM2 Kinase Regulates TIGIT Expression and Function in NK Cells from Multiple Myeloma Patients
24. Bone marrow mesenchymal stem cells regulate the dysfunction of NK cells via the T cell immunoglobulin and ITIM domain in patients with myelodysplastic syndromes
25. A Pig-a conditional knock-out mice model mediated by Vav-iCre: stable GPI-deficient and mild hemolysis
26. Role of EZH2 in bone marrow mesenchymal stem cells and immune–cancer interactions
27. Removal of heavy metals from fly ash using electrodialysis driven by a bioelectrochemical system: a case study of Pb, Mn, Cu and Cd.
28. Abnormal expression of CUX1 influences autophagy activation in paroxysmal nocturnal hemoglobinuria.
29. The difference of double-positive T cells and double-negative-T cells in myeloid neoplasms before and after chemotherapy, and after COVID-19 infection
30. Integrative proteomic and metabonomic profiling elucidates amino acid and lipid metabolism disorder in CA-MRSA-infected breast abscesses
31. Folic acid-coupled bovine serum albumin-modified magnetic nanocomposites from quantum-sized Fe3O4 and layered double hydroxide for actively targeted delivery of 5-fluorouracil
32. The role of TIM3+ NK and TIM3- NK cells in the immune pathogenesis of severe aplastic anemia.
33. Iron overload regulate the cytokine of mesenchymal stromal cells through ROS/HIF-1α pathway in Myelodysplastic syndromes
34. Quality of life considerations and management in patients with myelodysplastic syndrome
35. Developmental programming of Kupffer cells by maternal obesity causes fatty liver disease in the offspring
36. PB2136: THE VALUE OF PERIPHERAL BLOOD LYMPHOCYTE SUBSETS IN PREDICTING THE PROGNOSIS OF NEWLY DIAGNOSED MULTIPLE MYELOMA
37. P710: MONOCYTES MEDIATE NK CELL FUNCTION EXHAUSTION IN MDS PATIENTS VIA CD200/CD200R PATHWAY
38. P811: PIM2 KINASE REGULATES TIGIT EXPRESSION AND ENERGY METABOLISM IN NK CELLS OF PATIENTS WITH MULTIPLE MYELOMA
39. P764: DIFFERENTAL ERYTHROPOIESIS IN BONE MARROW OF PNH PATIENTS WERE REVEALED BY SINGLE-CELL SEQUENCING
40. PB1794: NATURAL FLAVONOIDS INHIBIT MYELOID NEOPLASM PROLIFERATION BY REGULATING PIM2 KINASE ACTIVITY
41. P758: THE MECHANISM OF ABNORMAL EXPRESSION AND MUTATION OF RBPJ GENE PROMOTING CLONE PROLIFERATION BY REGULATING PAF1 IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
42. P827: STUDY ON THE PERCENTAGE AND FUNCTION OF TSCM CELLS AND THE ANTITUMOR EFFECT IN VITRO AMPLIFICATION IN PATIENTS WITH MULTIPLE MYELOMA
43. Predictive Role of Immune Profiling for Survival of Multiple Myeloma Patients
44. LncRNA PCSK1N-202 regulates CD34 + hematopoietic cells proliferation in MDS patients via PIM2/HIF-1alpha
45. Efficacy and safety of inetetamab-containing regimens in patients with HER2-positive metastatic breast cancer: a real-world retrospective study in China
46. Metal-organic framework decorated with glycyrrhetinic acid conjugated chitosan as a pH-responsive nanocarrier for targeted drug delivery
47. Therapeutic strategies to enhance immune response induced by multiple myeloma cells
48. Study on the Effect of EZH2 Inhibitor Combined with TIGIT Monoclonal Antibody against Multiple Myeloma Cells
49. An overview of pim kinase as a target in multiple myeloma
50. Removal of heavy metals from fly ash using electrodialysis driven by a bioelectrochemical system: A case study of Pb, Mn, Cu and Cd
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.